Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01935934
Title Cabozantinib-S-Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

endometrial cancer

Therapies

Cabozantinib

Age Groups: adult
Covered Countries USA | CAN


No variant requirements are available.